Lili Sheng

机构：Shanghai University of Traditional Chinese Medicine, Shanghai First Maternity and Infant Hospital · ORCID：0000-0002-1142-6512

发表论文 127 篇 · 总被引 5529 次 · h-index 40

代表论文

• Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling (2023 · Nature Communications · 被引 134)
• Astragalus polysaccharides attenuate chemotherapy-induced immune injury by modulating gut microbiota and polyunsaturated fatty acid metabolism (2024 · Phytomedicine · 被引 83)
• Gut microbiota-brain bile acid axis orchestrates aging-related neuroinflammation and behavior impairment in mice (2024 · Pharmacological Research · 被引 45)
• Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial (2024 · Phytomedicine · 被引 24)
• High Fat Diet and High Sucrose Intake Divergently Induce Dysregulation of Glucose Homeostasis through Distinct Gut Microbiota-Derived Bile Acid Metabolism in Mice (2023 · Journal of Agricultural and Food Chemistry · 被引 23)
• Advancements in heparosan production through metabolic engineering and improved fermentation (2024 · Carbohydrate Polymers · 被引 21)